Sponsored By

The IDP program is a six-stage process through which customer projects are efficiently managed from the initial idea to serial production.

PlasticsToday Staff

December 20, 2016

2 Min Read
Sanner offers six-step product and packaging development program for pharma and medtech OEMs

You don’t stay in business for more than 120 years without internalizing a firm commitment to meeting evolving customer needs. Founded in 1894 and in its fourth generation as a family-owned business, Sanner GmbH (Bensheim, Germany) will showcase at Pharmapack 2017 in Paris how it continues to satisfy customers in 2016 and beyond: The IDP-Process, a program for the development and production of plastic packaging and components for pharmaceutical, medical and healthcare OEMs.

Standing for “Idea. Design. Product.,” IDP is a six-stage process through which customer projects are managed from the initial idea to serial production. “We develop smart, efficient and safe individual packaging solutions,” explains Sanner Managing Director Dirk Mähr, adding that the company supports its customers with “long-term expertise in the development of all kinds of primary packaging and medical devices.”

Fast, reliable market introduction of sophisticated medical products, such as inhalers with special spray geometries and user-friendly test-strip dispensers, require a matching packaging concept, according to Sanner GmbH, which has developed a program to help OEMs achieve that goal.

IDP begins with the concept phase, during which Sanner specialists develop different design approaches based on customer input and regulatory requirements. Although it is the earliest stage of the IDP process, production requirements are already taken into account to prevent surprises that might affect time lines. Once the customer has indicated the preferred solutions, the concepts are further elaborated in the design phase, notes Sanner. In the prototype phase, the required equipment and product samples are qualified and tested. In the industrialization phase, the final manufacture, installation and qualification of production equipment and the production parameters are specified. This process is validated in the implementation phase. All documents required for the approval and registration of both drugs and packaging are dealt with in parallel as the program moves forward. The IDP process culminates with the roll-out phase for the customer, but not for Sanner: It supports customers with dedicated services over the entire product life cycle.

Meanwhile, Sanner continues to work on optimizing its internal processes, adds Mähr, to great success. “Ninety-eight percent of all deliveries arrive at their destination on time without any missing parts,” he says. “The complaint rate is less than one per 10 million parts supplied.” An integrated manufacturing execution system ensures 100% traceability of all parts. 

Sanner is the leading global manufacturer of desiccant caps, producing two billion plastic parts each year. As such, it offers a similar development program for desiccant packaging, which it will also feature at Pharmapack. Like the IDP Process, it is designed to support a safe, time-sensitive and cost-effective market introduction of new pharmaceutical and healthcare products. Based on the company motto—as much desiccant as needed, as little as possible—the focus is on the ideal interaction of product, desiccant and packaging, explains the company.

Pharmapack will be held at the exhibition grounds at the Porte de Versailles in Paris on Feb. 1 and 2, 2017. 

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like